Explore more publications!

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on February 2, 2026

Ringing in Your Ears? ASHA Shares Facts About a Common Yet Misunderstood Health Issue
Johns Hopkins Health Plans Executive Elected Chair of Medicare Advantage Plan Alliance Compliance Forum
PacBio Completes Sale of Short-Read Sequencing Assets
The Real Ironman Economy: How AI, Superfibers, and Defense Tech Could Theoretically Converge
Dandy Redefines the Chairside Experience with the Launch of Dandy Cart All-in-one workstation
MAPS and Columbia University Partner on First-of-its-Kind Study of MDMA-Assisted Couples Therapy
Cynet Appoints MacKenzie Brown as Vice President of Threat Intelligence Strategy
The Sequoia Project Releases Draft of Workgroup-Developed Best Practices for Providers Aimed at Simplifying Patient Access to Health Data
Nexalin Highlights its Expanding Body of Peer-Reviewed Neuroimaging Research Confirming its DIFS™ Technology as the Leader in Evidenced-Based Non-Invasive Brain Stimulation
Sparrow Appoints Biopharmaceutical Industry Veteran, Carlo Incerti, M.D. to its Board of Directors
Polaryx Therapeutics Announces Direct Listing on Nasdaq; Shares to Begin Trading Under the Symbol “PLYX”
Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care
CorMedix Therapeutics Announces Share Repurchase Program
Standard Dental Labs Announces Acquisition of BRLIT Dental Laboratory, Inc.
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
Quotient Therapeutics Appoints Seasoned Life Sciences Executive, Susan Keefe, as Chief Financial Officer
Madrigal Pharmaceuticals to Release Fourth-Quarter and Full-Year 2025 Financial Results and Host Webcast on February 19, 2026
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions